Provided by Tiger Fintech (Singapore) Pte. Ltd.

Accolade, Inc.

7.02
+0.0000
Volume:- -
Turnover:- -
Market Cap:575.59M
PE:-3.04
High:7.02
Open:7.02
Low:7.02
Close:7.02
Loading ...

Accolade: Transcarent to Finance Deal Through Fully-Committed Equity Financing Led by General Catalyst & Glen Tullman's 62 Ventures

THOMSON REUTERS
·
08 Jan

Accolade Inc Shares Halted for News Pending Premarket

THOMSON REUTERS
·
08 Jan

Accolade Inc expected to post a loss of 32 cents a share - Earnings Preview

Reuters
·
08 Jan

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
06 Jan

Boston Scientific, IBD Stock Of The Day, Has Surged 57% In 2024. This Is Why There's More Upside.

Blockhead
·
27 Dec 2024

Morgan Stanley Adjusts Price Target on Accolade to $5 From $6

MT Newswires Live
·
17 Dec 2024

Accolade price target lowered to $5 from $6 at Morgan Stanley

TIPRANKS
·
17 Dec 2024

Morgan Stanley Keeps Their Hold Rating on Accolade (ACCD)

TIPRANKS
·
17 Dec 2024

FDA says Boston Scientific Accolade pacemakers may need early replacement

TIPRANKS
·
17 Dec 2024

Accolade (ACCD) Upgraded to Buy: Here's Why

Zacks
·
04 Dec 2024

Bain Capital Credit boss Joshua Hartz resigns: sources

The Australian Financial Review
·
25 Nov 2024

Secondary Market for Crypto VC Funds Offers Bargains, Investor Says -- Market Talk

Dow Jones
·
21 Nov 2024

TransUnion Stock Gains 27% in the Past 6 Months: Here's Why

Zacks
·
20 Nov 2024

Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
24 Oct 2024

Here's Why Trane Technologies Stock is a Great Pick Right Now

Zacks
·
15 Oct 2024

Accolade price target lowered to $6 from $7 at Wells Fargo

TIPRANKS
·
11 Oct 2024

Accolade Financial Analysis: A Hold Rating Amid Revenue Growth Uncertainties and Operational Challenges

TIPRANKS
·
11 Oct 2024

Accolade (ACCD) Upgraded to Buy: Here's What You Should Know

Zacks
·
11 Oct 2024